Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical ...

Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

The health care products maker posted revenue of $3.17 billion in the period, which missed Street forecasts. Nine analysts surveyed by Zacks expected $3.24 billion. Henry Schein expects full-year ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...

Henry Schein (HSIC) reported $3.17 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 0.4%. EPS of $1.22 for the same period compares to $1.32 a ...

Henry Schein Inc. closed $12.62 short of its 52-week high ($82.63), which the company reached on February 27th.

Analysts' ratings for Henry Schein (NASDAQ:HSIC) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below summarizes their recent ratings, showcasing the ...

Henry Schein has finally disclosed a data breach following at least two back-to-back cyberattacks in 2023 by the BlackCat Ransomware gang, revealing that over 160,000 people had their personal ...